Bone health in older men
Maturitas · 2026-11 · 214 · 109125
DOI: 10.1016/j.maturitas.2026.109125 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Maturitas, 2026-11. Verfasst von Michail Krikelis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital…. Hauptthemen laut MEDLINE: Osteoporosis, Bone Density, Osteoporotic Fractures. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Senile osteoporosis in men remains under-recognized despite substantial fracture-related morbidity and higher post-fracture mortality than in women. Age-related bone loss in men involves progressive trabecular thinning, cortical deterioration, and declining sex steroid levels, while secondary causes, including hypogonadism, medications, and chronic diseases, account for up to 60% of cases. Current guidelines recommend assessment of bone mineral density (BMD) in men aged ≥70 years and earlier screening in those with clinical risk factors, complemented by fracture-risk assessment and evaluation for secondary causes. Management includes lifestyle and fall-prevention measures, with pharmacological treatment according to fracture risk. Bisphosphonates remain first-line therapy, with zoledronic acid demonstrating vertebral fracture reduction. Denosumab and anabolic agents increase BMD, although male-specific fracture data remain limited. Testosterone replacement improves BMD in hypogonadal men, but has not been shown to reduce the risk of major osteoporotic fractures. Despite effective therapies, fewer than 20% of men receive treatment following a fragility fracture. This review summarizes current evidence on the epidemiology, pathophysiology, diagnosis, and management of osteoporosis in men, emphasizing male-specific evidence and persisting knowledge gaps. It identifies important gaps in the management of osteoporosis in men and highlights the need for improved screening and secondary prevention, male-specific fracture trials, long-term safety data, and evidence on optimal treatment sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital, Athens, Greece.
- Department of Endocrinology, Diabetes and Metabolism, 424 General Military Hospital, Thessaloniki, Greece.
- Department of Internal Medicine, "G. Gennimatas" General Hospital, Thessaloniki, Greece.
- Centre of Expertise in Rare Endocrine Diseases, C.E.R.E.D -Disorders of Calcium and Phosphate Metabolism, Endocrinology Unit, 1st Department of Propaedeutic Internal Medicine, LAIKO General Hospital of Athens, National…
- 3rd Department of Internal Medicine, "Papageorgiou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
- Laboratory for Research of the Musculoskeletal System "Th. Garofalidis", Medical School, National and Kapodistrian University of Athens, KAT Hospital, Athens, Greece. Electronic address: stournis@med.uoa.gr.
Zitieren
APA
Krikelis, M., Divaris, E., Pappa, A., Kassi, E., Anagnostis, P., & Tournis, S. (2026). Bone health in older men. Maturitas, 214, 109125. https://doi.org/10.1016/j.maturitas.2026.109125
Vancouver
Krikelis M, Divaris E, Pappa A, Kassi E, Anagnostis P, Tournis S. Bone health in older men. Maturitas. 2026;214:109125. doi:10.1016/j.maturitas.2026.109125
BibTeX
@article{Krikelis2026,
author = {Krikelis, Michail and Divaris, Efstathios and Pappa, Anna and Kassi, Evanthia and Anagnostis, Panagiotis and Tournis, Symeon},
title = {Bone health in older men},
journal = {Maturitas},
year = {2026},
volume = {214},
pages = {109125},
doi = {10.1016/j.maturitas.2026.109125}
}
EUVIMED